知镜 Cognispect · 医学文献与研究工作台

IgG N-Glycosylation and Incident Neuropathy and Nephropathy in People With Type 2 Diabetes: A Pooled Analysis of Prospective Cohort Studies.

Martinez Escobedo C, Birukov A, Heijmans R, Kuxhaus O, Eichelmann F, Slieker RC, Memarian E, Simunic-Briski N, Rutters F, Blom MT, Riera M, Crespo M, Wuhrer M, Barrios C, van Hoek M, 't Hart LM, Sijbrands E, Lauc G, Schulze MB, Wittenbecher C.
Diabetes care · 2026-09-01 · PMID 42467059

文献摘要

Objective To examine whether IgG N-glycosylation patterns are prospectively associated with incident diabetic nephropathy and neuropathy. Research design and methods We analyzed IgG N-glycosylation profiles in four cohorts: EPIC-Potsdam, DiaGene, GenoDiabMar, and Hoorn DCS. Among 3,263 individuals with and without type 2 diabetes at profiling, 674 incident neuropathy and 639 incident nephropathy cases occurred after diabetes diagnosis. Associations of IgG N-glycan peaks (IgG-GPs) and traits with incident outcomes were examined using Cox models and meta-analyzed across cohorts. Results Agalactosylated, asialylated, and bisected IgG-GPs were associated with higher nephropathy risk (IgG-GP3: hazard ratio [HR] 1.13 [95% CI 1.04-1.24]; IgG-GP4: HR 1.15 [95% CI 1.05-1.26]), while galactosylated and sialylated IgG-GPs were associated with lower risk (IgG-GP14: HR 0.86 [95% CI 0.78-0.94]; IgG-GP18: HR 0.85 [95% CI 0.77-0.94]) (all false discovery rate Conclusions IgG N-glycosylation may reflect immune-related mechanisms relevant to diabetic nephropathy; but the evidence between IgG-GPs and diabetic neuropathy remains inconclusive.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。